EGFR antibodies in resectable metastatic colorectal liver metastasis: more harm than benefit?

Gholami, Sepideh, Grothey, Axel (March 2020) EGFR antibodies in resectable metastatic colorectal liver metastasis: more harm than benefit? The Lancet Oncology, 21 (3). pp. 324-326. ISSN 1470-2045

[thumbnail of 2020_Gholami_EGFR_antibodies_in_respectable.pdf]
Preview
PDF
2020_Gholami_EGFR_antibodies_in_respectable.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (217kB) | Preview
Item Type: Paper
Subjects: diseases & disorders
diseases & disorders > neoplasms
diseases & disorders > cancer > cancer types > colon cancer
diseases & disorders > cancer > cancer types > colon cancer
bioinformatics > genomics and proteomics > genetics & nucleic acid processing > protein structure, function, modification > protein types > EGFR
diseases & disorders > cancer > metastasis
CSHL Authors:
Communities: CSHL labs > Gholami Lab
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: March 2020
Date Deposited: 05 Oct 2023 18:09
Last Modified: 29 Jan 2024 21:21
Related URLs:
URI: https://repository.cshl.edu/id/eprint/41137

Actions (login required)

Administrator's edit/view item Administrator's edit/view item